» Articles » PMID: 20368228

Diabetes Mellitus is Associated with Plaque Classified As Thin Cap Fibroatheroma: an Intravascular Ultrasound Study

Overview
Publisher Sage Publications
Date 2010 Apr 7
PMID 20368228
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

We compared measures of ID coronary atherosclerosis between diabetic and non-diabetic patients enrolled in a prospective multinational IVUS registry. The region of interest was the most diseased 10 mm segment of a single coronary artery. Coronary plaque was quantified using greyscale IVUS and further classified by phenotype (ID-adaptive intimal thickening, ID-pathological intimal thickening, ID-TCFA, ID-fibroatheroma, or ID-fibrocalcific) using VH-IVUS. There was a non-significant trend for greater total plaque volume in diabetic (n=191) compared with non-diabetic (n=584) patients (94.8 vs. 88.1 mm(3), p=0.36, adjusted for multiple comparisons). There was a greater proportion of ID-TCFA among diabetic patients (21.6 vs. 13.6%, p=0.01 after adjustment for multiple comparisons; p=0.08 following multivariable adjustment for age and clinical demographics), while differences in pathological intimal thickening, fibroatheroma and fibrocalcific plaque were not significant between groups. ID-TCFA was more common in the most diseased 10 mm segment of diabetic than in non-diabetic coronary arteries. Multivariable adjustment demonstrated age and possibly the presence of diabetes to be independent predictors of ID-TCFA.

Citing Articles

Dysregulation of MMP2-dependent TGF-ß2 activation impairs fibrous cap formation in type 2 diabetes-associated atherosclerosis.

Singh P, Sun J, Cavalera M, Al-Sharify D, Matthes F, Barghouth M Nat Commun. 2024; 15(1):10464.

PMID: 39653743 PMC: 11628557. DOI: 10.1038/s41467-024-50753-8.


Morphologies and composition changes in nonculprit subclinical atherosclerosis in diabetic versus nondiabetic patients with acute coronary syndrome who underwent long-term statin therapy.

Meng P, Nong J, Xu Y, You W, Xu T, Wu X Sci Rep. 2023; 13(1):5338.

PMID: 37005448 PMC: 10067820. DOI: 10.1038/s41598-023-32638-w.


The incretin hormone GIP is upregulated in patients with atherosclerosis and stabilizes plaques in ApoE mice by blocking monocyte/macrophage activation.

Kahles F, Liberman A, Halim C, Rau M, Mollmann J, Mertens R Mol Metab. 2018; 14:150-157.

PMID: 29884547 PMC: 6034034. DOI: 10.1016/j.molmet.2018.05.014.


Plaque volume and plaque risk profile in diabetic vs. non-diabetic patients undergoing lipid-lowering therapy: a study based on 3D intravascular ultrasound and virtual histology.

Kovarnik T, Chen Z, Mintz G, Wahle A, Bayerova K, Kral A Cardiovasc Diabetol. 2017; 16(1):156.

PMID: 29212544 PMC: 5719721. DOI: 10.1186/s12933-017-0637-0.


Correlation between optical coherence tomography-derived intraluminal parameters and fractional flow reserve measurements in intermediate grade coronary lesions: a comparison between diabetic and non-diabetic patients.

Reith S, Battermann S, Hellmich M, Marx N, Burgmaier M Clin Res Cardiol. 2014; 104(1):59-70.

PMID: 25124054 DOI: 10.1007/s00392-014-0759-2.